Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2015 062 649.4 |
96 | EP file number | EAKZ | 15 81 7642.0 |
86 | WO file number | WAKZ | PCT/US2015/063667 |
97 | EP publication number | EPN | 3226842 |
87 | WO publication number | WPN | 2016090101 |
54 | Designation/title | TI | ANTIKREBSZUSAMMENSETZUNGEN |
51 | IPC main class | ICM (ICMV) | A61K 9/14 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 9/20 (2006.01), A61P 13/08 (2006.01), A61P 35/00 (2006.01), A61P 35/04 (2006.01) |
22 | DE application date | DAT | Dec 3, 2015 |
96 | EP application date | EAT | Dec 3, 2015 |
86 | WO application date | WAT | Dec 3, 2015 |
43 | Date of first publication | OT | Jun 9, 2016 |
| Date of publication of grant | PET | Nov 25, 2020 |
71/73 | Applicant/owner | INH | Aragon Pharmaceuticals, Inc., Los Angeles, CA, US |
72 | Inventor | IN | VERRECK, Geert, 2340 Beerse, BE |
| Address for service | | RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 14196591 Dec 5, 2014
|
| Due date | FT FG | Dec 31, 2025 Annual fee for the 11th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003226842A1 Searchable text:
EP000003226842A1 Original document:
EP000003226842B1 Searchable text:
EP000003226842B1 Original document:
WO002016090101 Searchable text:
WO002016090101 |
43 | Date of first publication | EVT | Jun 9, 2016 |
| Date of the first transfer into DPMAregister | EREGT | Oct 12, 2017 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 3, 2025 (Show all update days)(Hide all update days)- Apr 3, 2025
- Procedures: Opposition procedure, Decision by EPO to maintain patent in full has become final, 12.03.2025: new
- Procedures: Opposition procedure, Patent maintained in full by EPO, 12.03.2025: new
- Nov 7, 2024
- Jul 25, 2024
- Procedures: Procedure relating to PCT application, Publication of PCT application, 09.06.2016: deleted
- Nov 9, 2023; Jul 8, 2022; Nov 11, 2021; Oct 14, 2021; Sep 9, 2021; Feb 17, 2021; Dec 12, 2020; Dec 10, 2020; Nov 6, 2020; Nov 5, 2020; Jan 2, 2020; Aug 22, 2019; May 2, 2019
- Historical data not available for this/these date(s)
- Oct 12, 2017
- Date of the first transfer into DPMAregister
|